Abstract
The reliability of routine BCR-ABL RT-nested-PCR was evaluated in 1453 B-lineage ALL or hybrid leukemia at initial diagnosis by RT-nested-PCR. All BCR-ABL-positive (n = 642) and 176 BCR-ABL-negative samples underwent a second RT-PCR. In 518 patients, karyotyping and/or FISH was compared to the BCR-ABL status. The second RT-PCR revealed in 155/642 initially positive samples a divergent result (153 BCR-ABL-negative, two other transcripts) that in most cases turned out to be caused by contaminations in the first RT-nested-PCR. Confirmatory RT-PCR detected 2/176 false negative first RT-nested-PCR results. Thirty-nine specimens remained ambiguous despite different RT-PCR approaches. As far as cytogenetic evaluation and FISH is available (n = 23), the majority but not all patients with an ambiguous RT-PCR result were Ph-negative (n = 18). RT-nested-PCR and cytogenetics yielded in 346 of 383 evaluable samples a concordant result. Differing results are given and account in part to the lower sensitivity of karyotyping. Taken together, confirmed RT-PCR detected BCR-ABL fusion transcripts consistently in 487 out of 1453 ALL samples (c-ALL: 43%, pre-B ALL: 34%, pro-B ALL: 5%, B-ALL: 0%, hybrid leukemia: 5/11). Since false positive initial RT-nested-PCR data were frequent, either confirmatory second RT-PCR or FISH analysis is warranted to guarantee sensitive and reliable results of utmost clinical relevance.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bartram CR, de Klein A, Hagemeijer A, van Agthoven T, Geurts van Kessel A, Bootsma D, Grosveld G, Ferguson-Smith MA, Davies T, Stone M, Heisterkamp N, Stephenson JR, Groffen J . Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukemia Nature 1983 306: 277–280
Heisterkamp N, Stam K, Groffen J, de Klein A, Grosveld G . Structural organization of the bcr gene and its role in the Ph′ translocation Nature 1985 315: 758–761
Fainstein E, Marcelle C, Rosner A, Canaani E, Gale RP, Dreazen O, Smith SD, Croce CM . A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukemia Nature 1987 330: 386–391
Saglio G, Guerrasio A, Rosso C, Zaccaria A, Tassinari A, Serra A, Rege Cambrin G, Mazza U, Gavosto F . New type of BCR/ABL junction in Philadelphia chromosome-positive chronic myelogenous leukemia Blood 1990 76: 1819–1824
Nowell PC, Hungerford DA . A minute chromosome in human chronic granulocytic leukemia Science 1960 132: 1497
Pane F, Frigeri F, Sinona M, Luciano L, Ferrara F, Cimino R, Meloni G, Saglio G, Salvatore F, Rotoli B . Neurophilic-chronic myelogenous leukemia: A distinct disease with a specific molecular marker (BCR-ABL with c3a2 junction) Blood 1996 88: 2410–2414
Schrappe M, Aricó M, Harbott J, Biondi A, Zimmermann M, Conter V, Reiter A, Valsecchi MG, Gadner H, Basso G, Bartram CR, Lampert F, Riehm H, Masera G, for the German–Austrian–Swiss BFM Study Group and the Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) . Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome Blood 1998 92: 2730–2741
Bloomfield CD, Goldman AI, Alimena G, Berger R, Borgström GH, Brandt L, Catovsky D, de la Chapelle A, Dewald GW, Garson OM, Garwicz S, Golumb HM, Hossfeld DK, Lawler SD, Mitelman F, Nilsson P, Pierre RV, Phillip P, Prigogina E, Rowley JD, Sakurai M, Sandberg AA, Secker Walker LM, Tricot G, Van Den Berghe H, Van Orshoven A, Vuopio P, Whang-Peng J . Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia Blood 1986 67: 415–420
Maurer J, Janssen JWG, Thiel E, van Denderen J, Ludwig W-D, Aydemir Ü, Heinze B, Fonatsch C, Harbott J, Reiter A, Riehm H, Hoelzer D, Bartram CR . Detection of chimeric BCR-ABL genes in acute lymphoblastic leukemia by the polymerase chain reaction Lancet 1991 337: 1055–1058
Westbrook CA, Hooberman AL, Spino C, Dodge RK, Larson RA, Davey F, Wurster-Hill DH, Sobol RE, Schiffer C, Bloomfield CD . Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a cancer and leukemia group B study (8762) Blood 1992 80: 2983–2990
Kantarjian HM, O'Brien S, Smith TL, Cortes J, Giles FJ, Beran M, Pierce S, Huh Y, Andreeff M, Koller C, Ha CS, Keating MJ, Murphy S, Freireich EJ . Results of treatment with Hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia J Clin Oncol 2000 18: 547–561
Larson RA, Dodge RK, Burns P, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR, Hooberman AL, Westbrook CA, Arthur DC, George SL, Bloomfield CD, Schiffer CA . A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8811 Blood 1995 85: 2025–2037
Kantarjian H, Talpaz M, Estey E, Ku S, Kurzrock R . What is the contribution of molecular studies to the diagnosis of BCR-ABL-positive disease in adult acute leukemia Am J Med 1994 96: 133–138
Rieder H, Bonwetsch C, Jansen LAJ, Maurer J, Janssen JWG, Schwartz S, Ludwig W-D, Gassmann W, Bartram CR, Thiel E, Löffler H, Gökbuget N, Hoelzer D, Fonatsch C . High rate of chromosome abnormalities detected by fluorescence in situ hybridization using BCR and ABL probes in adult acute lymphoblastic leukemia Leukemia 1998 12: 1473–1481
Dewald GW, Wyatt WA, Juneau AL, Carlson RO, Zinsmeister AR, Jalal SM, Spurbeck JL, Silver RT . Highly sensitive fluorescence in-situ-hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia Blood 1998 91: 3357–3365
Janssen JWG, Fonatsch C, Ludwig WD, Rieder H, Maurer J, Bartram CR . Polymerase chain reaction analyis of BCR-ABL sequences in adult Philadelphia chromosome-negative acute lymphoblastic leukemia patients Leukemia 1992 6: 463–464
Bennett JM, Catovsky D, Daniel MT, Flanchrin G, Galton DAG, Gralnick HR, Sultan C . Proposals for the classification of the acute leukemias Br J Haematol 1976 33: 451–458
Thiel, E, Kranz BR, Raghavachar A, Bartram CR, Löffler H, Messerer D, Ganser A, Ludwig WD, Büchner T, Hoelzer D . Prethymic phenotype and genotype of pre-T (CD7+/ER−)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia Blood 1989 73: 1247–1258
Ludwig WD, Rieder H, Bartram CR, Heinze B, Schwartz S, Gassmann W, Löffler H, Hossfeld D, Heil G, Handt S, Heyll A, Diedrich H, Fischer K, Weiss A, Völkers B, Aydemir Ü, Fonatsch C, Gökbuget N, Thiel E, Hoelzer D . Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B lymphoblastic leukemia: results of the german multicenter trials GMALL 03/87 and 04/89 Blood 1998 92: 1898–1909
Burmeister T, Maurer J, Aivado M, Elmaagacli AH, Grünebach F, Held KR, Heß G, Hochhaus A, Höppner W, Lentes KU, Lübbert M, Schäfer KL, Schafhausen P, Schmidt CA, Schüler F, Seeger FK, Seelig R, Thiede C, Viehmann S, Weber C, Wilhelm S, Christmann A, Clement JH, Ebener U, Enczmann J, Leo R, Schleuning M, Schoch R, Thiel E . Quality assurance in RT-PCR-based BCR/ABL diagnostics – results of an interlaboratory test and a standardization approach Leukemia 2000 14: 1850–1856
Cross NCP, Melo JV, Feng L, Goldman JM . An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders Leukemia 1994 8: 186–189
Fonatsch C, Schaadt M, Kirchner HH, Diehl V . A possible correlation between the degree of karyotype aberrations and the rate of sister chromatid exchanges in lymphoma lines Int J Cancer 1980 26: 749–756
Mitelman F . ISCN. An International System of Human Cytogenetic Nomenclature Karger: Basel 1995
ISCN . Guidelines for Cancer Cytogenetics: Supplement to An International System for Human Cytogenetic Nomenclature Karger: Basel 1992
Fière D, Lepage E, Sebban C, Boucheix C, Gisselbrecht C, Vernant J-P, Varet B, Broustet A, Cahn JY, Rigal-Hughet F, Witz F, Michaux J-L, Michallet M, Reiffers J . Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy J Clin Oncol 1993 11: 1990–2001
Preti HA, O'Brien S, Giralt S, Beran M, Pierce S, Kantarjian HM . Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients Am J Med 1994 97: 60–65
Kantarjian H M, Talpaz M, Dhingra K, Estey E, Keating MJ, Ku S, Trujillo J, Huh Y, Stass S, Kurzrock R . Significance of the p210 versus p190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia Blood 1991 78: 2411–2418
Radich JP, Kopecky KJ, Boldt DH, Head D, Slovak ML, Babu R, Kirk J, Lee A, Kessler P, Appelbaum F, Gehly G . Detection of BCR-ABL fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction Leukemia 1994 8: 1688–1695
van Rhee F, Hochhaus A, Lin F, Melo JV, Goldman JM, Cross NCP . p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemia Blood 1996 87: 5213–5217
Lugo TG, Pendergast AM, Muler AJ, Witte ON . Tyrosine kinase activity and transformation potency of BCR-ABL oncogene product Science 1990 247: 1079–1082
McLaughlin J, Chianese E, Witte OB . Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells Mol Cell Biol 1989 8: 1866–1974
Quackenbush RC, Reuther GW, Miller JP, Courtney KD, Pear WS, Pendergast AM . Analysis of the biologic properties of p230 BCR-ABL reveals unique and overlapping properties with the oncogenic p185 and p210 BCR-ABL tyrosine kinase Blood 2000 95: 2913–2921
Drexler HG, Thiel E, Ludwig WD . Review of the incidence and clinical relevance of myeloid antigen-positive adulte lymphoblastic leukaemia Leukemia 1991 5: 637–645
Kwok S, Higuchi R . Avoiding false positives with PCR Nature 1989 339: 237–238
Horsburgh CR Jr, Ou CY, Jason J, Homberg SD, Lifson AR, Moore JL, Ward JW, Seage GR, Mayer KH, Evatt BL, Schochetman G, Jaffe HW . Concordance of polymerase chain reaction with human immunodeficiency virus antibody detection J Infect Dis 1990 162: 542–545
Druker BF, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M . Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome N Engl J Med 2001 344: 1038–1042
Acknowledgements
The excellent technical assistance of A Sindram, P Haveman, S Havemann, D Erz, K Weidenauer, R Bielen, E Strohmaier, A Wunderlich, U Spadinger and H Kessler is gratefully acknowledged. This work was supported by the Deutsche Krebshilfe, Federal Republic of Germany, Contract No. M84/92Hol and the Federal Ministry of Education and Research, Federal Republic of Germany, Contract No. 01ZP88045.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gleißner, B., Rieder, H., Thiel, E. et al. Prospective BCR-ABL analysis by polymerase chain reaction (RT-PCR) in adult acute B-lineage lymphoblastic leukemia: reliability of RT-nested-PCR and comparison to cytogenetic data. Leukemia 15, 1834–1840 (2001). https://doi.org/10.1038/sj.leu.2402304
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402304
Keywords
This article is cited by
-
Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008
Leukemia (2010)
-
Adult precursor B lymphoblastic leukemia in Shanghai, China: characterization of phenotype, cytogenetics and outcome for 137 consecutive cases
International Journal of Hematology (2009)
-
Why and how to quantify minimal residual disease in acute lymphoblastic leukemia?
Leukemia (2007)
-
Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects
Leukemia (2003)